Association of single-nucleotide polymorphism (SNP) in the 5-alpha-reductase gene (SRD5A2) with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer (TC) survivors.

Authors

H. Boer

Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands

H. Boer , C. Meijer , J. D. Dijck-Brouwer , I. P. Kema , J. D. Lefrandt , N. Zwart , H. M. Boezen , A. J. Smit , J. A. Gietema

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Sign-In

Similar Posters

insert_chart_outlined

Poster

2022 ASCO Annual Meeting

bookmark_border

Change in telomere length and cardiovascular risk in testicular cancer survivors.

First Author: Ellen L.D. Volders

insert_chart_outlined

Poster

2021 Genitourinary Cancers Symposium

bookmark_border

Paternity, relationship, sexual activity and fertility in testicular cancer (TC) survivors (TCS): Results from a single institution observational prospective study.

First Author: Davide Bimbatti

insert_chart_outlined

Poster

2016 ASCO Annual Meeting

bookmark_border

Genome-wide association study (GWAS) of cisplatin-related hearing loss in testicular cancer survivors (TCS) to reveal associated variant in Wolfram syndrome 1 (WFS1) gene.

First Author: Heather E. Wheeler

insert_chart_outlined

Poster

2016 ASCO Annual Meeting

bookmark_border

Genome wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.

First Author: Omar El Charif